Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): A large propensity score-matched population-based study

類似資料

• Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation
  著者:: Zeidan, Amer M., 等
  出版事項: (2018)
• Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents
  著者:: Zeidan, Amer M., 等
  出版事項: (2019)
• Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic Leukemia in the United States: A large population-based study
  著者:: Zeidan, Amer M., 等
  出版事項: (2017)
• Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States
  著者:: Zeidan, Amer M., 等
  出版事項: (2020)
• Severe atypical herpes zoster as an initial symptom of fatal myelodysplastic syndrome with refractory anemia and blast excess (RAEB II)
  著者:: Wollina U, 等
  出版事項: (2017-05-01)